MISPLACED MANDATE: AN EXAMINATION OF FDA'S SILICONE BREAST IMPLANT POLICY

DSpace/Manakin Repository

MISPLACED MANDATE: AN EXAMINATION OF FDA'S SILICONE BREAST IMPLANT POLICY

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Granoff, Susan N. en_US
dc.date.accessioned 2012-07-06T21:39:10Z
dc.date.issued 1995 en_US
dc.identifier.citation MISPLACED MANDATE: AN EXAMINATION OF FDA'S SILICONE BREAST IMPLANT POLICY (1995 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965595
dc.description.abstract Why did the Food and Drug Administration (FDA) suddenly call for a forty-five day moratorium on silicone gel breast implants in 1 992 and then ban virtually all cosmetic breast implants' only months after an FDA advisory panel had recommended that silicone breast implants remain on the market for both reconstructive and cosmetic uses?2 Is FDA's policy, which remains in force today, justified? What is FDA's mandate, and has FDA overstepped it in banning cosmetic breast implants? en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject silicone breast implants en
dc.subject breast augmentation en
dc.subject cosmetic surgery en
dc.title MISPLACED MANDATE: AN EXAMINATION OF FDA'S SILICONE BREAST IMPLANT POLICY en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T21:39:10Z

Files in this item

Files Size Format View
sgranoff.pdf 126.4Kb PDF View/Open
sgranoff.rtf 47.63Kb RTF file View/Open
sgranoff.html 37.21Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters